Pharmacotherapy for Opioid Use Disorder is organized by College of Psychiatric and Neurologic Pharmacists (CPNP).
Activity Dates: 12/19/2019 - 12/19/2022
ACPE Contact Hours: 2.0
This learning activity is one session within CPNP’s 17-session Opioid Use Disorder Education Program intended to help pharmacists be part of the solution in addressing this public health crisis.
• Explain the basic mechanism of action, dosing and dosage forms, adverse effects, monitoring parameters, and patient considerations for buprenorphine/naloxone, methadone, and naltrexone.
• Describe the American Society of Addiction Medicine (ASAM) levels of care and appropriate use in clinical practice.
• Develop a care plan for a patient prescribed buprenorphine/naloxone, methadone, or naltrexone for the outpatient treatment of OUD.
• Recommend non-pharmacologic treatments and wrap-around services for a patient being treated for OUD.